OptiRTP Selected to Present at 2026 SelectUSA Investment Summit
The SelectUSA Investment Summit at the Gaylord National Resort & Convention Center, National Harbor, Maryland. Photo: SelectUSA / U.S. Department of Commerce.
OptiRTP has been selected to present in the Defense Pitching Session at the 2026 SelectUSA Investment Summit, engaging with investors, government representatives, and industry leaders from across the United States and international markets.
SelectUSA is the U.S. government’s premier investment promotion event, bringing together high-growth companies and stakeholders focused on facilitating business expansion into the United States.
OptiRTP will represent New Zealand as part of the official delegation, reflecting the company’s continued engagement with U.S. partners as it builds its commercial operations.
Reported outcomes from high-performance athletes using Optimum Bio Sound Therapy (OBST) across sleep, recovery, and pain management continue to align with broader areas of interest in force readiness and veteran health. These areas are increasingly relevant in discussions around scalable, non-invasive therapeutic approaches.
Participation in the Defense Pitching Session provides an opportunity to engage directly with U.S. stakeholders as OptiRTP continues to develop its presence in the market.
Event details: 2026 SelectUSA Investment Summit
About OptiRTP
OptiRTP is a New Zealand health-technology company developing Optimum Bio Sound Therapy (OBST), a neuromodulation platform registered as an FDA Class I medical device. The platform has delivered over 352,393 therapy hours to more than 1,100 users. www.OptiRTP.com